{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:54:46Z","timestamp":1792364086430,"version":"4.4.0"},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,8,1]]},"DOI":"10.2169\/internalmedicine.0687-22","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T22:13:43Z","timestamp":1690841623000},"page":"2273-2277","source":"Crossref","is-referenced-by-count":9,"title":["Dermatomyositis Presenting with Generalized Subcutaneous Edema"],"prefix":"10.2169","volume":"62","author":[{"given":"Hiroaki","family":"Nishioka","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Shindo","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 362: 971-982, 2003.","DOI":"10.1016\/S0140-6736(03)14368-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lundberg IE, Tj\u00e4rnlund A, Bottai M, et al. 2017 European League against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76: 1955-1964, 2017.","DOI":"10.1136\/annrheumdis-2017-212786"},{"key":"3","unstructured":"3. Nitsche A, San Agust\u00edn PG, Amado V, Prina AP, Corsaro G. Trunk and abdominal wall edema in dermatomyositis. Medicina (B Aires) 48: 331-332, 1988."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Smyth AE, Bell AL, Crone M. Acute oedematous dermatomyositis. Ann Rheum Dis 59: 575, 2000.","DOI":"10.1136\/ard.59.7.574b"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gorelik O, Almoznino-Sarafian D, Alon I, et al. Acute inflammatory myopathy with severe subcutaneous edema, a new variant? Report of two cases and review of the literature. Rheumatol Int 20: 163-166, 2001.","DOI":"10.1007\/s002960000093"},{"key":"6","unstructured":"6. Mrou\u00e9 KH, Sharara NH, Rbeiz JG, Arayssi TK. A case of edematous dermatomyositis. J Rheumatol 30: 2722-2723, 2003."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Werner DCG, Appenzeller SBM, Costallat LT. Acute dermatomyositis with subcutaneous generalized edema. Clin Rheumatol 25: 898-900, 2006.","DOI":"10.1007\/s10067-005-0053-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ito Y, Kawabata D, Yukawa N, et al. Severe subcutaneous generalized edema in a patient with dermatomyositis. Mod Rheumatol 17: 171-173, 2007.","DOI":"10.1007\/s10165-006-0560-9"},{"key":"9","first-page":"21","volume":"7","author":"L Dunkley","year":"2007","unstructured":"9. Dunkley L, Jawad ASM. Subcutaneous oedema as a presenting feature of polymyositis\/dermatomyositis: a poor prognostic indicator? Grand Rounds 7: 21-25, 2007.","journal-title":"Grand Rounds","ISSN":"https:\/\/id.crossref.org\/issn\/1470-5206","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lee KH, Lim SR, Kim YJ, et al. Acute dermatomyositis associated with generalized subcutaneous edema. Rheumatol Int 28: 797-800, 2008.","DOI":"10.1007\/s00296-008-0520-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chai Y, Bertorini TE, Li YD, Mitchell C, Guan H. Limb edema and anasarca associated with severe dermatomyositis: report of four cases. Neuromuscul Disord 21: 439-442, 2011.","DOI":"10.1016\/j.nmd.2011.03.003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Haroon M, Eltahir A, Harney S. Generalized subcutaneous edema as a rare manifestation of dermatomyositis: clinical lesson from a rare feature. J Clin Rheumatol 17: 135-137, 2011.","DOI":"10.1097\/RHU.0b013e318214f1a9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Jung KD, Kim PS, Park HY, et al. Dermatomyositis associated with generalized subcutaneous edema and Evans syndrome. J Am Acad Dermatol 66: 144-147, 2012.","DOI":"10.1016\/j.jaad.2009.10.035"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Milisenda JC, Doti PI, Prieto-Gonz\u00e1lez S, Grau JM. Dermatomyositis presenting with severe subcutaneous edema: five additional cases and review of the literature. Semin Arthritis Rheum 44: 228-233, 2014.","DOI":"10.1016\/j.semarthrit.2014.04.004"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yoshida N, Kaieda S, Yoshimura S, Ida H. Facial and laryngeal edema in a patient with dermatomyositis. Intern Med 53: 921, 2014.","DOI":"10.2169\/internalmedicine.53.2142"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Grinnell M, Keyes E, Vazquez T, et al. Dermatomyositis associated with hyponatremia and anasarca. JAAD Case Rep 16: 86-89, 2021.","DOI":"10.1016\/j.jdcr.2021.08.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tu J, McLean-Tooke A, Junckerstorff R. Increasing recognition of dermatomyositis with subcutaneous edema - is this a poorer prognostic marker? Dermatol Online J 20: 21244, 2014.","DOI":"10.5070\/D3201021244"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Strowd LC, Jorizzo JL. Review of dermatomyositis: establishing the diagnosis and treatment algorithm. J Dermatolog Treat 24: 418-421, 2013.","DOI":"10.3109\/09546634.2012.697540"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sherzai D, Rao R, Nguyen C, Schulz E, Sherzai A. Lymphatic blockage and severe edema in dermatomyositis: lessons from this case and others. Case Rep Clin Pathol 1: 21-25, 2014.","DOI":"10.5430\/crcp.v1n2p12"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Arima K, Origuchi T, Tamai M, et al. RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis 64: 1653-1655, 2005.","DOI":"10.1136\/ard.2004.032995"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Grundtman C, Tham E, Ulfgren AK, Lundberg IE. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis Rheum 58: 3224-3238, 2008.","DOI":"10.1002\/art.23884"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Trallero-Aragu\u00e1s E, Rodrigo-Pend\u00e1s J\u00c1, Selva-O'Callaghan A, et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 64: 523-532, 2012.","DOI":"10.1002\/art.33379"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Aussy A, Boyer O, Cordel N. Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer. Front Immunol 8: 992, 2017.","DOI":"10.3389\/fimmu.2017.00992"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ito K, Imafuku S, Hamaguchi Y, Fujimoto M, Nakayama J. Case report of anti-transcription intermediary factor-1-\u03b3\/\u03b1 antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor. J Dermatol 40: 567-569, 2013.","DOI":"10.1111\/1346-8138.12141"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Masiak A, Kulczycka J, Czuszy\u0144ska Z, Zdrojewski Z. Clinical characteristics of patients with anti-TIF1-\u03b3 antibodies. Reumatologia 54: 14-18, 2016.","DOI":"10.5114\/reum.2016.58756"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Duchesne M, Leonard-Louis S, Landon-Cardinal O, et al. Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis. Brain Pathol 30: 867-876, 2020.","DOI":"10.1111\/bpa.12844"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Albayda J, Pinal-Fernandez I, Huang W, et al. Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients. Arthritis Care Res (Hoboken) 69: 1771-1776, 2017.","DOI":"10.1002\/acr.23188"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Butt Z, Patel L, Das MK, Mecoli CA, Ramji A. NXP-2 positive dermatomyositis: a unique clinical presentation. Case Rep Rheumatol 2017: 4817275, 2017.","DOI":"10.1155\/2017\/4817275"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Mugii N, Hasegawa M, Matsushita T, et al. Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies. PLoS One 11: e0154746, 2016.","DOI":"10.1371\/journal.pone.0154746"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/15\/62_0687-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T03:23:37Z","timestamp":1691205817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/15\/62_0687-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0687-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"article-number":"0687-22"}}